Blood/immune cells | NanoVation Therapeutics

Gene expression for cancer immunotherapy

Gene expression for cancer immunotherapy

by NanoVation | Mar 30, 2023 | Blood/immune cells, bone marrow, Extrahepatic, spleen, Tissue

Adminstration route: i.v. Platform technology: lcLNP™ Modality: mRNA Indication: not disclosed Strategy:...

Gene expression for cancer immunotherapy

Gene editing in extrahepatic tissues for treating genetic diseases

by NanoVation | Mar 30, 2023 | Blood/immune cells, bone marrow, Extrahepatic, Tissue

Adminstration route: i.v. Platform technology: lcLNP™ Modality: mRNA/gRNA Indication: not disclosed Strategy:...

Gene expression for cancer immunotherapy

mRNA vaccine for viral diseases

by NanoVation | Mar 30, 2023 | Blood/immune cells, Extrahepatic, Tissue, virus

Adminstration route: i.m. Platform technology: combined Modality: mRNA Indication: SARS & ASF Strategy:...